The president’s advocacy of the anti-malarial drug has created tensions in his administration, and fears among doctors that it could unnecessarily expose patients to risks.
from NYT > U.S. > Politics https://ift.tt/2UJebgA
via IFTTT
from NYT > U.S. > Politics https://ift.tt/2UJebgA
via IFTTT
Комментариев нет:
Отправить комментарий